-
Wharton S, le Roux CW, Bozkurt B, Platz E, Bleckert G, Ajaz Hussain S, Brueckmann M, Startseva E, Kloer IM, Kaplan LM.
Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes Diabetes Obes Metab
-
Donovan CM, Buffini M, Walton J, Kehoe L, Kearney J, Flynn A, Nugent A, McNulty B.
Trends in the weight status of adults in Ireland between 1990 and 2024 Eur J Nutr
-
Purnell JQ, Le Roux CW.
Metabolic and appetitive regulation of adipocyte mass during treatment of obesity J Intern Med
-
Farrell E, Nadglowski J, Hollmann E, le Roux CW, McGillicuddy D.
Correction: The nature of the relationship between obesity and mental health: an IMI2 SOPHIA qualitative study Int J Obes (Lond)
- Alawami F, Novaes O, Gibney J, Phelan N, Behan LA, Owens L. The metabolic benefits associated with semaglutide use in obese women with polycystic ovary syndrome- a retrospective study of clinical practice Ir J Med Sci
-
Pandey A, Moroney M, Verma S, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Petrie MC, Rönnbäck C, Domdey A, Rasmussen S, Chinnakondepalli KM, Patel S, Kosiborod MN.
Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme Eur J Heart Fail
-
Monzo L, Savarese G, Mullens W, Abdin A, Bozkurt B, Chioncel O, El Hadidi S, Gorter TM, Inciardi RM, Petrie MC, Schiattarella GG, Stolfo D, Metra M, Girerd N.
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document Eur J Heart Fail
- Platz E, Kaplan LM, le Roux CW, Wharton S, Burger S, Hussain SA, Brueckmann M, Startseva E, Fey C, Kosiborod MN, Bozkurt B. Survodutide for the Treatment of Obesity: Baseline Characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial JACC Heart Fail
-
Drews-Botsch C, Harrington S.
Obesity and physical activity in children with early vision problems: a secondary analysis of data from the Growing-Up in Ireland study BMC Pediatr
-
Mondoh A, Crotty M, le Roux CW.
Tirzepatide vs. semaglutide: clinical decision-making in the GLP-1 landscape Expert Opin Pharmacother